First, the data from TCGA Pan-Cancer Atlas showed that CECR2 mRNA expression in colorectal cancer ranked at a moderate to medium level among the 32 different cancer types, comprising 10,967 samples from 10,953 patients (Fig. S3). This evidence concerns the gene CECR2 and cancer.